NanoVibronix, Inc. is a healthcare equipment company specializing in the design, development, and marketing of medical devices that utilize proprietary low-intensity surface acoustic wave (SAW) technology. Its main focus is on non-invasive biological response-activating devices aimed at addressing key medical needs, particularly in pain therapy, biofilm prevention in medical catheters, and wound healing. Notable products include PainShield, a wearable patch delivering low-frequency ultrasound for drug-free pain management, and UroShield, an ultrasound actuator that attaches to catheters to reduce bacterial biofilm formation and lower the risk of catheter-associated infections. The company also has pipeline products targeting wound healing and potentially other therapeutic applications, all leveraging the core SAW platform. NanoVibronix outsources its manufacturing, while prioritizing research, regulatory compliance, and the development of distributor partnerships to expand its market reach. Established in 2003 and based in Texas, NanoVibronix serves hospitals, long-term care facilities, pain clinics, and individual patients worldwide, playing a significant role in advancing non-invasive therapies in the healthcare sector.
Markedsdata leveret af TwelveData og Morningstar